As of 2026-03-11, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 36.86 USD. This relative valuation is based on P/E multiples. With the latest stock price at 73.23 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -49.7%.
The range of the Relative Valuation is 24.41 - 51.86 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.1x - 42.5x | 40.2x |
| Forward P/E multiples | 27.6x - 35.5x | 31.8x |
| Fair Price | 24.41 - 51.86 | 36.86 |
| Upside | -66.7% - -29.2% | -49.7% |
| Date | P/E |
| 2026-03-10 | 108.26 |
| 2026-03-09 | 129.63 |
| 2026-03-06 | 128.72 |
| 2026-03-05 | 129.48 |
| 2026-03-04 | 137.23 |
| 2026-03-03 | 135.06 |
| 2026-03-02 | 137.84 |
| 2026-02-27 | 142.76 |
| 2026-02-26 | 141.27 |
| 2026-02-25 | 140.50 |
| 2026-02-24 | 140.79 |
| 2026-02-23 | 138.71 |
| 2026-02-20 | 138.02 |
| 2026-02-19 | 136.03 |
| 2026-02-18 | 138.16 |
| 2026-02-17 | 131.02 |
| 2026-02-13 | 133.92 |
| 2026-02-12 | 130.93 |
| 2026-02-11 | 134.87 |
| 2026-02-10 | 135.93 |
| 2026-02-09 | 134.25 |
| 2026-02-06 | 137.88 |
| 2026-02-05 | 134.82 |
| 2026-02-04 | 135.31 |
| 2026-02-03 | 129.40 |
| 2026-02-02 | 119.00 |
| 2026-01-30 | 116.43 |
| 2026-01-29 | 116.31 |
| 2026-01-28 | 116.70 |
| 2026-01-27 | 120.60 |
| 2026-01-26 | 120.81 |
| 2026-01-23 | 122.20 |
| 2026-01-22 | 127.77 |
| 2026-01-21 | 127.77 |
| 2026-01-20 | 122.51 |
| 2026-01-16 | 131.11 |
| 2026-01-15 | 129.96 |
| 2026-01-14 | 128.24 |
| 2026-01-13 | 124.71 |
| 2026-01-12 | 124.12 |
| 2026-01-09 | 120.02 |
| 2026-01-08 | 124.59 |
| 2026-01-07 | 129.93 |
| 2026-01-06 | 129.97 |
| 2026-01-05 | 128.98 |
| 2026-01-02 | 117.42 |
| 2025-12-31 | 116.05 |
| 2025-12-30 | 116.19 |
| 2025-12-29 | 118.24 |
| 2025-12-26 | 118.96 |